Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

12263 from 12462 pages
No results were found for the filter!
Atidortoxumab
Atidortoxumab

Item number: TGM-T82949-1mg

Description: Atidortoxumab is a human monoclonal antibody (IgG1kappa) targeting Staphylococcus aureus alpha toxin [1].
CAS 1939108-95-8
Please request pricing for this article.
Review
ASGPR modulator-1
ASGPR modulator-1

Item number: TGM-T82958-50mg

Description: Compound 5TJX (ASGPR modulator-1) is a macrocyclic compound utilized in the study of protein-protein interactions [1]. Target: Others
CAS 2052968-88-2
Please request pricing for this article.
Review
ASB20123
ASB20123

Item number: TGM-T82961-50mg

Description: ASB20123, a CNP/ghrelin chimeric peptide, promotes bone growth and has potential research applications in growth disorders and dwarfism [1].
Please request pricing for this article.
Review
ARUK2007145
ARUK2007145

Item number: TGM-T82964-50mg

Description: ARUK2007145 is a potent, cell-active inhibitor targeting both PI5P4Kalpha and PI5P4Kgamma isoforms with pIC50 values of 7.3 and 8.1, respectively [1]. Target: Others
Please request pricing for this article.
Review
ARI-1
ARI-1

Item number: TGM-T82971-50mg

Description: ARI-1 is a receptor tyrosine kinase-like orphan receptor 1 (ROR1) inhibitor that binds to ROR1's extracellular Frizzled domain, effectively inhibiting aberrant ROR1 expression linked to non-small cell lung cancer (NSCLC) and EGFR-TKI-induced drug resistance. It modulates PI3K/AKT/mTOR signaling pathways...
Please request pricing for this article.
Review
Aplyronine C
Aplyronine C

Item number: TGM-T82982-50mg

Description: Aplyronine C, an active compound, exhibits potent antitumor activity and demonstrates cytotoxicity against HeLa-S3 cells, with an IC50 value of 22 nM, suggesting potential use in cancer research [1].
CAS 151923-86-3
Please request pricing for this article.
Review
Aplithianines A
Aplithianines A

Item number: TGM-T82984-50mg

Description: Aplithianines A effectively inhibits J-PKAcalpha with an IC50 value of 1 µM and displays higher potency against wild-type PKA, achieving an IC50 of 84 nM by competitively interacting with the ATP pocket [1]. Target: PKA
Please request pricing for this article.
Review
AP 811 acetate
AP 811 acetate

Item number: TGM-T82993-50mg

Description: AP 811 acetate is a selective antagonist of the atrial natriuretic peptide clearance receptor (ANP-CR, NPR3), with a high affinity (K_i = 0.48 nM) and over 20,000-fold selectivity for NPR3 compared to NPR1, effectively inhibiting ANP-induced pump stimulation [1] [2].
Please request pricing for this article.
Review
Anzurstobart
Anzurstobart

Item number: TGM-T82994-10mg

Description: Anzurstobart, a fully human monoclonal anti-SIRPalpha antibody, is characterized by high-affinity binding and inhibition of the CD47-SIRPalpha interaction, which is known to suppress macrophage activity. Anzurstobart enhances macrophage-mediated phagocytosis of diffuse large B-cell lymphoma (DLBCL) cell...
Keywords: BMS-986351 , BMS986351 , CC95251 , CC-95251
From 187.00€ *
Review
Antiviral agent 33
Antiviral agent 33

Item number: TGM-T82995-50mg

Description: Antiviral agent 33 (compound 1c), a double-stranded DNA (dsDNA) virus inhibitor, exhibits potent inhibitory activity with IC50 values of 0.0790 µM for VACV and 0.1572 µM for AdV5, and is a candidate for oral administration [1]. Target: Others
Please request pricing for this article.
Review
Antitumor agent-107
Antitumor agent-107

Item number: TGM-T83009-50mg

Description: Antitumor agent-107 (compound 5h) is an anticancer agent exhibiting potent inhibitory activity against leukemia cell lines (GI50 = 0.32-1.34 µM) and demonstrating broad-spectrum antitumor effects across various human cancer cell lines (GI50 = 0.35-9.43 µM) [1]. Target: Others
Please request pricing for this article.
Review
Antitumor agent-106
Antitumor agent-106

Item number: TGM-T83010-50mg

Description: Antitumor Agent-106 (Compound 42) is a potent anticancer compound, demonstrating significant inhibitory activity (IC50 = 4.2-6.6 µM) against lung and colon cancer cell lines [1]. Target: Others
Please request pricing for this article.
Review
12263 from 12462 pages